HIV-1 Nef disrupts maturation of CD4+ T cells through CD4/Lck modulation. 2010

Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
Laboratory of Molecular Biology, Clinical Research Institute of Montreal, Montreal, Quebec, Canada. pavel.chrobak@ircm.qc.ca

The HIV-1 Nef protein is a major determinant of HIV-1 pathogenicity. It has been found to induce thymocyte depletion, but the mechanisms involved are not completely understood. Also, nothing is known about its effects on thymocyte selection. We used the CD4C/HIV(Nef) transgenic (Tg) mice, which develop a profound CD4(+) T cell lymphopenia, to study their thymic development. We report that HIV-1 Nef causes depletion of double-positive thymocytes and impairs selection and lineage commitment of CD4(+) single-positive thymocytes. This latter defect could be relieved by increasing the affinity of the TCR-MHC interaction or by allowing CD4(+) T cell maturation to proceed in absence of the CD4 tail, in double-Tg (Nef × CD4(tailless)) mice or in the presence of constitutively active Tg Lck(Y505F). These rescue strategies also resulted in reversal of peripheral CD4(+) T cell lymphopenia. Our data indicate that impairment of Lck-mediated CD4 coreceptor signaling by Nef is an important in vivo mechanism of HIV-1 pathogenesis.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
May 1994, Journal of immunology (Baltimore, Md. : 1950),
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
February 2014, Retrovirology,
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
February 1995, Virology,
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
March 1996, The Journal of biological chemistry,
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
November 2018, Journal of immunology (Baltimore, Md. : 1950),
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
September 1996, FEBS letters,
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
May 1994, AIDS research and human retroviruses,
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
July 2000, AIDS (London, England),
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
August 2009, Journal of virology,
Pavel Chrobak, and Marie-Chantal Simard, and Nathalie Bouchard, and Thomas Mutushi Ndolo, and Joël Guertin, and Zaher Hanna, and Vibhuti Dave, and Paul Jolicoeur
June 2012, Future virology,
Copied contents to your clipboard!